Is Androgenetic Alopecia Exclusively Inherited from the Maternal Family Tree ?

Androgenetic alopecia (AGA), commonly referred to as male pattern baldness (MPB) in men and female pattern hair loss (FPHL) in women, is among the most prevalent forms of hair loss worldwide. Characterized by a distinct pattern of progressive hair thinning, AGA affects millions of individuals, influencing both physical appearance and psychological well-being. Its clinical significance has led to extensive research into the underlying causes, especially the role that heredity plays in determining susceptibility. A long-standing myth persists that AGA is inherited exclusively from the maternal side of one’s family. While several genetic factors are indeed linked to the X chromosome (inherited from the mother in the case of men), the reality is far more complex. This article aims to clarify that complexity, elucidating the interplay of hormonal and genetic determinants in AGA and tackling the question: Is androgenetic alopecia exclusively inherited from the maternal family tree?

Overview of Androgenetic Alopecia: AGA arises from a combination of genetic predisposition and hormonal influences, predominantly the action of androgens such as dihydrotestosterone (DHT). Hair follicles on the scalp are sensitive to DHT, a potent derivative of testosterone, through specific androgen receptors. In those prone to hair loss, DHT binds to androgen receptors in scalp hair follicles and triggers a progressive miniaturization process. Over time, these affected hair follicles produce progressively thinner and shorter hairs until they are eventually lost.

In men, AGA characteristically starts with a receding hairline at the temples and a thinning crown, which may progress to partial or almost complete baldness on the top of the scalp. In women, the pattern differs, with generalized thinning usually occurring at the central parting, though complete baldness is uncommon. Regardless of gender, the pathology involves heightened sensitivity of hair follicles to DHT due to specific genetic factors.

The Myth of Maternal Inheritance Exclusivity: The popular claim that men inherit their hair loss from their mother’s side – specifically their maternal grandfather – is a partial truth stemming from historical genetic findings. Indeed, a key gene involved in AGA is the androgen receptor (AR) gene located on the X chromosome. Males receive their X chromosome from their mothers and their Y chromosome from their fathers. Since the AR gene resides on the X chromosome, it is tempting to conclude that the mother’s genes are entirely to blame for MPB in men. However, the focus solely on the AR gene in AGA is an oversimplification.

While the AR gene is pivotal for androgen sensitivity, modern genetic studies have identified multiple loci throughout the genome – on several autosomes (non-sex chromosomes) – that also contribute to AGA. Additionally, one inherits 50% of one’s autosomal genes from the mother and 50% from the father. Thus, paternal genetic contributions cannot be dismissed. It is now widely accepted that androgenetic alopecia is polygenic, meaning that multiple genes, both maternal and paternal in origin, synergize to influence the risk and onset of AGA.

Elucidating the Genetic Underpinnings: Several genes are involved in the inheritance of androgenetic alopecia

  1. Androgen Receptor (AR) Gene on the X Chromosome: The AR gene is perhaps the most well-known genetic factor implicated in AGA. It encodes the androgen receptor protein, which mediates the biological actions of testosterone and DHT. Variants (polymorphisms) in the AR gene can affect how sensitive or efficient the receptor is in binding androgens. Therefore, men carrying certain AR gene polymorphisms may experience earlier or more pronounced hair loss. Because men inherit the X chromosome from their mothers, these polymorphisms may reflect the mother’s genetic contribution. However, it is worth emphasizing that a mother passes on her X chromosome randomly, and not all men carry risky AR variants associated with AGA.
  2. Other Contributing Genes: Recent genome-wide association studies (GWAS) have revealed multiple other genes and gene regions linked to AGA. These include variations located on chromosomes 20, 3, 5, and others. Many of these genes do not reside on the X chromosome, indicating that an individual’s father also contributes genetically to the risk of developing AGA. For instance, variants near the EDA2R gene on the X chromosome and variations on chromosome 20p11 have been repeatedly associated with AGA in different populations. Possessing certain risk alleles on chromosome 20p11 can be as influential – if not more – than carrying high-risk AR alleles. Such findings underscore that both maternal and paternal genetic factors contribute to AGA.
  3. Polygenic and Multifactorial Inheritance: The inheritance of AGA is best described as polygenic and multifactorial, meaning that several genes interact with hormonal and environmental factors to result in hair loss patterns. An individual may inherit risk alleles from either parent, or both, and the overall combination of these genes, plus lifestyle factors (e.g., diet, stress, general health status), will shape how early and how severely one might manifest AGA. It is also important to note that ethnic background influences the prevalence and severity of AGA. Certain populations exhibit higher frequencies of genetic variants associated with hair loss compared to others, further illustrating the complexity of these genetic interactions.

Hormonal Regulation and Its Genetic Basis: Testosterone, produced primarily in the testes in men and in the ovaries and adrenal glands in women, is converted to DHT by the enzyme 5α-reductase. There are two main isoforms of this enzyme, Type I and Type II, encoded by the SRD5A1 and SRD5A2 genes, respectively. Genetic variations in these genes can affect an individual’s rate of DHT production. Moreover, not everyone produces the same amounts of DHT, nor do all hair follicles share the same sensitivity threshold.

This variability underscores that susceptibility to AGA goes beyond a single gene. A person may harbor variations in genes encoding for the androgen receptor, the 5α-reductase enzyme, or proteins involved in hair follicle cycling (such as the WNT and Hedgehog signaling pathways). With so many overlapping genetic and molecular factors at play, attributing hair loss risk exclusively to the maternal lineage is clearly an oversimplification.

Paternal Contributions and Shared Risk: Because a significant number of genes involved in AGA are located on autosomes, one’s father contributes crucially to the inheritance of hair loss risk. For example, if a man’s father exhibits pronounced balding, it may indicate strong genetic influences for hair loss on autosomal chromosomes that can be passed on to future generations. Indeed, an individual whose father has early and severe hair loss may inherit one or more of those risk alleles and exhibit a similar pattern, even if his AR gene polymorphism – derived from the mother – does not predispose him as strongly to baldness.

Moreover, the paternal lineage’s effect can combine with or even outweigh the maternal lineage’s effect in certain families. The synergy between maternal- and paternal-inherited risk alleles, along with hormonal and environmental modifiers, shapes the unique pattern, onset, and severity of AGA for each individual.

Why the Myth Persists: Although the notion that men “get baldness from their mother’s father” is oversimplified, there are historical and cultural reasons for its persistence. Early genetic analyses focused on the X chromosome link, largely because the AR gene was one of the first genes identified with a strong association with male pattern baldness. Additionally, the pattern of inheritance for some families does appear consistent with X-linked traits, reinforcing the narrative that baldness “skips” father-to-son transmission and is instead passed down through the maternal side.

In reality, many families display a more complicated pattern of inheritance, where both men and women in multiple generations can exhibit signs of thinning hair. Moreover, some individuals with robust paternal and maternal hairlines still develop AGA through newly arising genetic variants or less obvious inherited combinations of risk alleles. The inheritance pattern of AGA is thus far too variable for neat categorization into a single maternal or paternal line.

Implications for Diagnosis, Counseling, and Management: Understanding the multifactorial and polygenic basis of AGA can significantly improve genetic counseling and clinical management. Individuals concerned about hair loss might consult a dermatologist or a trichologist for personalized evaluation, bearing in mind the following points:

  1. Family History Assessment: A thorough analysis of hair loss in the family – encompassing both maternal and paternal relatives – offers insights into potential genetic contributions. However, the absence of a strong family history does not exclude the possibility of AGA, given that de novo mutations or milder expressions in relatives might mask its presence.
  2. Genetic Testing and Personalized Medicine: While no single genetic test can definitively predict the onset and severity of AGA, advanced genomic screening tools that assess multiple risk alleles could become clinically relevant in the future. Such personalized medicine approaches may allow for early interventions, such as topical minoxidil, oral finasteride, or low-level laser therapy, possibly delaying progression.
  3. Lifestyle Interventions: Though genetic predisposition exerts a major influence, certain lifestyle factors – nutrition, stress management, and scalp health – can modulate AGA severity. Collaboration between healthcare professionals, including nutritionists and mental health specialists, can offer a holistic approach to reducing the burden of hair loss.
  4. Psychological Support: Hair loss can have profound psychosocial implications. Understanding that both sides of the family can influence one’s risk might help mitigate the stigma or blame aimed at the maternal lineage. Furthermore, psychological support and counseling can help individuals adapt to hair loss and maintain self-esteem.

Conclusion: Androgenetic alopecia is a complex, polygenic, and multifactorial disorder influenced by various genes – some located on the X chromosome, others on autosomes – and modulated by hormonal and environmental factors. While it is true that the androgen receptor gene on the X chromosome plays a critical role in the sensitivity of hair follicles to androgens, it is by no means the sole determinant of AGA. Consequently, the long-held belief that AGA is inherited exclusively from the maternal family tree is an oversimplification that overlooks the significant role played by paternal genetic contributions and other modifier genes.

Individuals with a family history of androgenetic alopecia on either the maternal or paternal side – or both – are likely to have an elevated risk. Nevertheless, the ultimate expression of AGA also depends on non-genetic factors, such as hormonal regulation, age, stress, and overall health. This recognition underscores the need to move beyond simplistic notions of maternal inheritance and approach AGA as a condition shaped by a broad constellation of genes and lifestyle parameters. For those concerned about hair thinning, seeking medical expertise, exploring therapeutic interventions, and receiving proper support can help manage AGA effectively. Most importantly, it is critical to dispel misconceptions and provide a balanced understanding of how genetics truly shapes the risk of androgenetic alopecia, highlighting the contributions of both parents in determining who is likely to develop hair loss over their lifetime.

Bibliography

1.
Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest. 1993 Aug;92(2):903–10.
1.
Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S70-80.
1.
Hoffmann R. Male androgenetic alopecia. Clin Exp Dermatol. 2002 Jul;27(5):373–82.
1.
Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002 Nov 19;4(22):1–11.
1.
Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet. 2005 Jul;77(1):140–8.
1.
Richards JB, Yuan X, Geller F, Waterworth D, Bataille V, Glass D, et al. Male-pattern baldness susceptibility locus at 20p11. Nat Genet. 2008 Nov;40(11):1282–4.
1.
Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res. 2015;4(F1000 Faculty Rev):585.
1.
Heilmann-Heimbach S, Herold C, Hochfeld LM, Hillmer AM, Nyholt DR, Hecker J, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nat Commun. 2017 Mar 8;8:14694.
1.
Pirastu N, Joshi PK, de Vries PS, Cornelis MC, McKeigue PM, Keum N, et al. GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. Nat Commun. 2017 Nov 17;8(1):1584.
1.
Li Y, Huang H, Liang B, Xiao FL, Zhou FS, Zheng XD, et al. Association study reveals a susceptibility locus with male pattern baldness in the Han Chinese population. Front Genet. 2024;15:1438375.